| scholarly article | Q13442814 |
| P2093 | author name string | Alan H Stephenson | |
| Elizabeth A Bowles | |||
| Madelyn S Hanson | |||
| Randy S Sprague | |||
| P2860 | cites work | Reduced exercise arteriovenous O2 difference in Type 2 diabetes | Q51687699 |
| Red blood cell regulation of microvascular tone through adenosine triphosphate. | Q54056545 | ||
| Deformation-induced ATP release from red blood cells requires CFTR activity. | Q54117015 | ||
| Phosphorylation of PDE3B by Phosphatidylinositol 3-Kinase Associated with the Insulin Receptor | Q59466721 | ||
| Characteristics of human erythrocyte insulin receptors | Q67341307 | ||
| Structure of the human erythrocyte insulin receptor | Q68857327 | ||
| Characterization of the insulin receptor kinase from human erythrocytes | Q70191457 | ||
| The erythrocyte as a regulator of vascular tone | Q70986072 | ||
| Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus | Q71012849 | ||
| Heterogeneity of oxygen delivery impairs oxygen extraction by peripheral tissues: theory | Q71689687 | ||
| ATP: the red blood cell link to NO and local control of the pulmonary circulation | Q71978359 | ||
| Essential role of phosphatidylinositol 3-kinase in insulin-induced activation and phosphorylation of the cGMP-inhibited cAMP phosphodiesterase in rat adipocytes. Studies using the selective inhibitor wortmannin | Q72150649 | ||
| Studies on adenosine 3′,5′-monophosphate phosphodiesterase of human erythrocyte membranes | Q72864661 | ||
| Ontogeny of catecholamine and adenosine receptor-mediated cAMP signaling of embryonic red blood cells: role of cGMP-inhibited phosphodiesterase 3 and hemoglobin | Q73254143 | ||
| Insulin stimulates NHE1 activity by sequential activation of phosphatidylinositol 3-kinase and protein kinase C zeta in human erythrocytes | Q73442542 | ||
| Insulin-induced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes: possible role for protein kinase B but not mitogen-activated protein kinase or p70 S6 kinase | Q74013266 | ||
| Differential modulation of adenylyl cyclases I and II by various G beta subunits | Q74088857 | ||
| Reduced expression of G(i) in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release | Q79386804 | ||
| Japanese IGT subjects with high insulin response are far more frequently associated with the metabolic syndrome than those with low insulin response | Q79755164 | ||
| Iloprost- and isoproterenol-induced increases in cAMP are regulated by different phosphodiesterases in erythrocytes of both rabbits and humans | Q24316393 | ||
| Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMP | Q24336559 | ||
| Erythrocytes: oxygen sensors and modulators of vascular tone | Q24653317 | ||
| Insulin sensitivity and Lp(alpha) concentrations in normoglycemic offspring of type 2 diabetic parents | Q24796609 | ||
| Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents | Q27991377 | ||
| Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt | Q28511947 | ||
| Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure | Q28579532 | ||
| The red blood cell as an oxygen sensor: what is the evidence? | Q33888508 | ||
| Insulin inhibits low oxygen-induced ATP release from human erythrocytes: implication for vascular control | Q34003283 | ||
| Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family | Q34070572 | ||
| Defects in microvascular haemodynamics during prediabetes: contributor or epiphenomenon? | Q34111033 | ||
| Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake | Q34519649 | ||
| Microvascular vasodilatation in feet of newly diagnosed non-insulin dependent diabetic patients | Q35179319 | ||
| Red blood cell-derived ATP as a regulator of skeletal muscle perfusion | Q35621214 | ||
| Do we need to target 'prediabetic' hypertensive patients? | Q36306242 | ||
| Relationship of insulin resistance to microvascular dysfunction in subjects with fasting hyperglycaemia | Q36848310 | ||
| Red not dead: signaling in and from erythrocytes | Q36981005 | ||
| Loss of epinephrine stimulated synthesis of cyclic adenosine 3':5' monophosphate during maturation of rabbit and human reticulocytes | Q39948922 | ||
| Apparent multiple forms of cyclic AMP phosphodiesterase from rat erythrocytes | Q40007877 | ||
| Microvascular function in human diabetes. A physiological perspective | Q40550044 | ||
| Hormonal stimulation of adenylyl cyclase through Gi-protein beta gamma subunits | Q41635276 | ||
| Regulation of skeletal muscle perfusion during exercise | Q41760246 | ||
| Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling | Q42991205 | ||
| Role of erythrocyte in regulating local O2 delivery mediated by hemoglobin oxygenation | Q43610552 | ||
| Receptor-mediated activation of the heterotrimeric G-protein Gs results in ATP release from erythrocytes | Q43658728 | ||
| Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP release | Q43730250 | ||
| Dynamics of microvascular oxygen pressure during rest-contraction transition in skeletal muscle of diabetic rats | Q44103904 | ||
| Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention | Q44333422 | ||
| Heterotrimeric G protein Giis involved in a signal transduction pathway for ATP release from erythrocytes | Q44654252 | ||
| Cyclic nucleotide phosphodiesterase activity in the plasma and erythrocytes of normal and diabetic rats | Q44664290 | ||
| NO inhibits signal transduction pathway for ATP release from erythrocytes via its action on heterotrimeric G protein Gi. | Q44836445 | ||
| Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus | Q44895987 | ||
| Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes | Q45199153 | ||
| Isolated impaired fasting glucose and peripheral insulin sensitivity: not a simple relationship | Q46686470 | ||
| Rabbit erythrocytes possess adenylyl cyclase type II that is activated by the heterotrimeric G proteins Gs and Gi. | Q46895879 | ||
| Human erythrocytes contain Ca2+, calmodulin-dependent cyclic nucleotide phosphodiesterase which is involved in the hydrolysis of cGMP. | Q47694797 | ||
| Regulation of Gi and Go by mastoparan, related amphiphilic peptides, and hydrophobic amines. Mechanism and structural determinants of activity | Q48916036 | ||
| Reduced microvascular hyperaemia in subjects at risk of developing type 2 (non-insulin-dependent) diabetes mellitus. | Q51596790 | ||
| P433 | issue | 2 | |
| P921 | main subject | preproinsulin | Q7240673 |
| human erythrocyte | Q111535219 | ||
| P304 | page(s) | 256-262 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | Experimental Biology and Medicine | Q15716535 |
| P1476 | title | Insulin inhibits human erythrocyte cAMP accumulation and ATP release: role of phosphodiesterase 3 and phosphoinositide 3-kinase | |
| P478 | volume | 235 |
| Q35601360 | A selective phosphodiesterase 3 inhibitor rescues low PO2-induced ATP release from erythrocytes of humans with type 2 diabetes: implication for vascular control |
| Q43373010 | Akt/mTOR Role in Human Foetoplacental Vascular Insulin Resistance in Diseases of Pregnancy. |
| Q26799623 | Blood cells: an historical account of the roles of purinergic signalling |
| Q37947681 | Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments |
| Q35055216 | Cyclic phosphatidic acid stimulates cAMP production and inhibits growth in human colon cancer cells |
| Q33917040 | Defects in oxygen supply to skeletal muscle of prediabetic ZDF rats |
| Q24598135 | Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communication |
| Q37781833 | Erythrocytes as controllers of perfusion distribution in the microvasculature of skeletal muscle |
| Q37723601 | Kinetics of extracellular ATP in mastoparan 7-activated human erythrocytes |
| Q58728940 | Leptin Stimulates Cellular Glycolysis Through a STAT3 Dependent Mechanism in Tilapia |
| Q43499334 | Liposomal delivery of a phosphodiesterase 3 inhibitor rescues low oxygen-induced ATP release from erythrocytes of humans with type 2 diabetes |
| Q35812849 | Lymphatic vascular integrity is disrupted in type 2 diabetes due to impaired nitric oxide signalling |
| Q48238409 | Mechanisms of C-peptide-mediated rescue of low O2-induced ATP release from erythrocytes of humans with type 2 diabetes. |
| Q39295378 | Purinergic control of red blood cell metabolism: novel strategies to improve red cell storage quality |
| Q35173532 | Regulation of extracellular ATP in human erythrocytes infected with Plasmodium falciparum |
| Q37835208 | Regulatory volume decrease and P receptor signaling in fish cells: mechanisms, physiology, and modeling approaches. |
| Q36535827 | Role of erythrocyte-released ATP in the regulation of microvascular oxygen supply in skeletal muscle. |
| Q37440642 | Synergistic effects of C-peptide and insulin on low O2-induced ATP release from human erythrocytes |
| Q38084698 | Tissue oxygen demand in regulation of the behavior of the cells in the vasculature. |
| Q42321513 | Toward a multiscale description of microvascular flow regulation: o(2)-dependent release of ATP from human erythrocytes and the distribution of ATP in capillary networks |
| Q36005577 | Vascular disease in pre-diabetes: new insights derived from systems biology |
Search more.